Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets
Unknown statusNCT05687929
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
1. To observe the clinical analgesic effect, safety and adverse reactions of acetylaconitine. 2. To study and analyze the main influencing factors of the acetylaconitine tablets.
Study details
- Official title
- Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets
- Conditions
- Sponsor
- Ke Ma
- Organization
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Start date
- 2023-03-27
- Primary completion
- 2023-06-15
- Sex
- All
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with chronic pain \> 1 month and VAS \> 40 mm Patients who can take the acetylaconitine tablets orally Exclusion Criteria: * Patients who cannot communicate or receive follow-up Patients allergic to acetylaconitine Patients who have taken the acetylaconitine drugs orally
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05687929